1. Home
  2. AURA

AURA

Aura Biosciences Inc.

Logo Aura Biosciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 3:59pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Founded: 2007 Country:
United States
United States
Employees: N/A City: BOSTON
Market Cap: 356.4M IPO Year: 2021
Target Price: $21.00 AVG Volume (30 days): 185.4K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.93 EPS Growth: N/A
52 Week Low/High: $5.99 - $13.50 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: